DNA - 5885041

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • GlobeNewswire

    DNA Plc’s Annual Report including Board of Directors' Report and Financial Statements for 2019 is published

    DNA PLC STOCK EXCHANGE RELEASE 28 February 2020, 11:00 EET  DNA’s Annual Report 2019 was published today on 28 February 2020 on company's website: www.dna.fi/investors.

  • GlobeNewswire

    DNA Plc: Telenor Finland Holding Oy has gained title to all outstanding shares in DNA and the DNA shares have been delisted from Nasdaq Helsinki

    Telenor Finland Holding Oy ("Telenor") has on 3 February 2020 posted a security approved by the arbitral tribunal for the payment of the redemption price and the interest accruing thereon and thereby obtained title to all minority shares in DNA Oyj ("DNA") in accordance with Chapter 18, Section 6 of the Finnish Companies Act ("Companies Act"). After the security has been posted and the title to the shares transferred, the minority shareholders of DNA being parties to the redemption proceedings are entitled to receive only the redemption price and the interest payable thereon. Upon DNA's application, Nasdaq Helsinki Ltd ("Nasdaq Helsinki") has on 17 December 2019 decided that DNA's shares will be delisted from the official list of Nasdaq Helsinki after Telenor has obtained title to all the outstanding shares in DNA in the redemption proceedings in accordance with the Companies Act.

  • GlobeNewswire

    DNA Plc: Arbitral tribunal has confirmed Telenor Finland Holding Oy's redemption right regarding DNA's minority shares and trading in DNA's shares has been suspended

    The arbitral tribunal appointed by the Redemption Board of the Finland Chamber of Commerce has today confirmed that Telenor Finland Holding Oy ("Telenor") has the right to redeem the minority shares in DNA Plc ("DNA") and that Telenor has the right to obtain title to the minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price and the interest accruing thereon. Following DNA's application, Nasdaq Helsinki Ltd ("Nasdaq Helsinki") has on 17 December 2019 confirmed that that the quotation of DNA' shares will be terminated and the shares will be delisted from the official list of Nasdaq Helsinki as soon as possible after Telenor has obtained title to all outstanding shares in DNA in the redemption proceedings.

  • GlobeNewswire

    DNA Plc’s Financial Statements Bulletin 2019

    DNA’s net sales and EBITDA reach record levels in 2019, driven by strong mobile service revenue DNA PLC STOCK EXCHANGE RELEASE 28 JANUARY 2020, 8:30 AM EET This is a.

  • GlobeNewswire

    DNA’s financial information and Annual General Meeting in 2020

    DNA PLC STOCK EXCHANGE RELEASE 20 December 2019, 15:00 pm EET In 2020, DNA will publish its financial statements and interim reports as follows: •   28 January 2020: Financial.

  • GlobeNewswire

    DNA Plc: Arbitral tribunal appointed for the arbitration proceedings concerning the redemption of minority shares in DNA

    DNA PLC STOCK EXCHANGE RELEASE 17 December 2019, 14:00 pm EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA,.

  • GlobeNewswire

    DNA applies for delisting of its shares from Nasdaq Helsinki

    The board of directors of DNA Plc ("DNA") has decided to apply for the termination of public trading in DNA's shares and for delisting of DNA's shares from the official list of Nasdaq Helsinki Ltd ("Nasdaq Helsinki"). Telenor Finland Holding Oy ("Telenor") owns more than nine-tenths (9/10) of all shares and voting rights in DNA and has therefore initiated arbitration proceedings in accordance with Chapter 18 of the Finnish Companies Act ("Companies Act") in order to redeem all the remaining shares in DNA held by the minority shareholders. Telenor is requesting the arbitral tribunal to be appointed for the redemption proceedings to confirm Telenor's redemption right and that Telenor has the right to obtain title to all DNA's minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price.

  • GlobeNewswire

    DNA Plc: Special representative appointed for the arbitration proceedings concerning the redemption of minority shares in DNA Plc

    Telenor Finland Holding Oy ("Telenor") has on 11 October 2019 commenced mandatory redemption proceedings in respect of DNA Plc's ("DNA") minority shares by applying for arbitration proceedings to be initiated in accordance with Chapter 18, Section 4 of the Finnish Companies Act in order to redeem the remaining shares in DNA. As a result of Telenor's application for initiation of arbitration proceedings, the Redemption Board of the Finland Chamber of Commerce has petitioned the District Court of Helsinki for the appointment of a special representative to look after the interests of DNA's minority shareholders in the arbitration during the redemption proceedings.

  • GlobeNewswire

    DNA Plc: Jukka Leinonen appointed new Nordic cluster head for Telenor Group

    DNA's CEO Jukka Leinonen has been appointed head of Telenor Group’s Nordic cluster and a member of Telenor’s Group Executive Management. Part of his new role is to act as the chair of Telenor Sweden and Telenor Denmark. - Jukka Leinonen is a long-term telco leader with more than 30 years in the ICT industry.

  • GlobeNewswire

    Decisions of DNA Plc's Extraordinary General Meeting and organisation of Board of Directors

    DNA Plc's Extraordinary General Meeting was held in Helsinki on 31 October 2019. The Extraordinary General Meeting approved the proposals of the shareholders' Nomination Committee for the number of Board members, members of the Board and their remuneration. The number of board members remains seven, and the following current Board members were re-elected; Anni Ronkainen, Kirsi Sormunen and Tero Ojanperä.

  • GlobeNewswire

    DNA Plc’s Interim Report January-September 2019: DNA’s net sales and EBITDA grew strongly

    DNA PLC STOCK EXCHANGE RELEASE 22 OCTOBER 2019, 8:30 AM EEST DNA arranges two news conferences today. News conference for media and analysts in Finnish is held at 10:00 am.

  • GlobeNewswire

    DNA Plc: Managers' transactions – Pekka Väisänen

    DNA PLC MANAGERS' TRANSACTIONS 16 October, 2019 at 10:30 am EET DNA has received a notification from Pekka Väisänen, DNA's Senior Vice President, Consumer Business, of a.

  • GlobeNewswire

    DNA Plc: Final result of extended offer period of Telenor's mandatory public cash tender offer for the shares in DNA

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Telenor Finland Holding Oy (the "Offeror") commenced a mandatory public cash tender offer to acquire all of the issued and outstanding shares in DNA Plc ("DNA") that are not held by DNA or any of its group companies or by the Offeror or any of its group companies (the "Shares") (the "Tender Offer") on 29 August 2019. The initially scheduled offer period of the Tender Offer expired on 26 September 2019 at 4:00 pm (Finnish time) ("Initial Offer Period").

  • GlobeNewswire

    DNA raises its guidance for 2019

    DNA Plc, Stock Exchange Release, 15 October 2019 at 9:00 am EEST DNA’s operations have developed favourably in 2019, even though competition has remained intense. Net sales.

  • GlobeNewswire

    DNA Plc: Preliminary result of extended offer period of Telenor's mandatory public cash tender offer for the shares in DNA

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Telenor Finland Holding Oy (the "Offeror") commenced a mandatory public cash tender offer to acquire all of the issued and outstanding shares in DNA Plc ("DNA") that are not held by DNA or any of its group companies or by the Offeror or any of its group companies (the "Shares") (the "Tender Offer") on 29 August 2019. The initially scheduled offer period of the Tender Offer expired on 26 September 2019 at 4:00 pm (Finnish time) ("Initial Offer Period").

  • GlobeNewswire

    DNA's incentive schemes and matching shares plan are terminated - rewards are paid in cash

    DNA Plc's Board of Directors has on 3 October 2019 resolved to terminate DNA's long-term share-based incentive schemes for senior executives and other key employees and the matching shares plan for its personnel. The Board of Directors has also resolved on the payment of rewards thereunder in cash. The long-term share-based incentive schemes and the matching shares plan were initially disclosed by way of a stock exchange releases on 31 January 2017 and 21 December 2018, respectively.

  • GlobeNewswire

    DNA Plc: Managers' transactions – Tero Ojanperä

    DNA PLC MANAGERS' TRANSACTIONS 4 March, 2019 at 15:00 pm EET DNA has received a notification from Tero Ojanperä, DNA's Board member, of a transaction made with DNA's financial.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Jukka Leinonen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST  DNA has received a notification from Jukka Leinonen, CEO, of a transaction made with DNA’s financial.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Pertti Korhonen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST DNA has received a notification from Pertti Korhonen, Chairman of the Board, of a transaction made with DNA’s.

  • GlobeNewswire

    DNA Plc: Managers' transactions – Anu Nissinen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EET DNA has received a notification from Anu Nissinen, DNA’s board member, of a transaction made with DNA's financial.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Pekka Väisänen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST DNA has received a notification from Pekka Väisänen, Senior Vice President, Consumer Business, of a transaction.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Jukka Ottela

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST DNA has received a notification from Jukka Ottela, Member of the Board, of a transaction made with DNA’s.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Timo Karppinen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST DNA has received a notification from Timo Karppinen, Chief Financial Officer, of a transaction made with DNA’s.

  • GlobeNewswire

    DNA Plc: Managers' transactions: Ted Roberts

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST DNA has received a notification from Ted Roberts, Member of the Board, of a transaction made with DNA’s.

  • GlobeNewswire

    DNA Plc: Managers' transactions – Kirsi Sormunen

    DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 at 15:00 pm EET DNA has received a notification from Kirsi Sormunen, DNA's Board member, of a transaction made with DNA's.